Breast Cancer
Showing NaN - NaN of 237
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Breast Cancer Trial in Los Angeles (Nature based exercise)
Recruiting
- Breast Cancer
- Nature based exercise
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Aug 2, 2022
Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)
Cancer, Breast Cancer, Colon Cancer Trial in Los Angeles (Change in knowledge, motivation, skills, and resources)
Withdrawn
- Cancer
- +4 more
- Change in knowledge, motivation, skills, and resources
-
Los Angeles, CaliforniaCharles R. Drew University of Medicine & Science
Jul 22, 2022
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,
Recruiting
- Advanced Malignant Neoplasm
- +5 more
- AMXI-5001:Dose Escalation Phase I
- AMXI-5001:Dose Expansion Phase II
-
Phoenix, Arizona
- +7 more
Jul 18, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Breast Cancer, Brain Metastases, HER2-positive Breast Cancer Trial in Los Angeles (Tucatinib, Pembrolizumab, Trastuzumab)
Withdrawn
- Breast Cancer
- +3 more
- Tucatinib
- +2 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jun 28, 2022
Breast Cancer Trial in Los Angeles (Carbohydrate restricted dietary intervention, standard of care aromatase inhibitors)
Recruiting
- Breast Cancer
- Carbohydrate restricted dietary intervention
- standard of care aromatase inhibitors
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jun 30, 2022
Breast Cancer Trial in Worldwide (Amcenestrant (SAR439859), Letrozole)
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Pancreatic Cancer, Breast Cancer, Gastric Cancer Trial in United States (NGM831, NGM831 plus pembrolizumab)
Recruiting
- Pancreatic Cancer
- +15 more
- NGM831
- NGM831 plus pembrolizumab
-
Gilbert, Arizona
- +4 more
Jun 21, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer, HER2-positive Breast Cancer Trial in Los Angeles (Omit breast radiation)
Not yet recruiting
- Breast Cancer
- HER2-positive Breast Cancer
- Omit breast radiation
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 10, 2022
Breast Cancer Trial in United States (radiation, drug, biological)
Recruiting
- Breast Cancer
- Focal Radiation therapy
- +2 more
-
Los Angeles, California
- +6 more
Apr 29, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan (T-DXd)
- Ado-trastuzumab emtansine (T-DM1)
-
Los Angeles, California
- +163 more
Apr 1, 2022
Breast Cancer Trial in Worldwide (Palbociclib, Standard Adjuvant Endocrine Therapy)
Active, not recruiting
- Breast Cancer
- Palbociclib
- Standard Adjuvant Endocrine Therapy
-
Mobile, Alabama
- +437 more
Mar 21, 2022
Breast Cancer Trial in Los Angeles (Diabetes Prevention Program-based lifestyle change intervention (DPP), Highly
Recruiting
- Breast Cancer
- Diabetes Prevention Program-based lifestyle change intervention (DPP)
- Highly Microbiota-Accessible Foods (HMAFs) intervention
-
Los Angeles, CaliforniaUCLA Center for Cancer Prevention & Control Research
Apr 1, 2022